Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

SARM1

sterile alpha and TIR motif containing 1

translation score 0.52, read 2026-10-21; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.04 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocyte progenitor cells; strongest in kupffer cells0.75
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
22 Parkinson's papers of 4590.59
pathways
Reactome
5 pathways; mostly immune signalling0.90

No case: the score is under the bar. Receipt 5654

Sealed predictions

  1. SARM1 in dopamine neurons, braak-0.14 (p 0.714) → -0.78 (p 0.013)receipt 5662
  2. SARM1 in oligodendrocytes, braak-0.12 (p 0.767) → -0.28 (p 0.459)receipt 5661

Swarm cases

receipt 5662: SARM1 in dopamine neurons, braak

power
full sample -0.37 (p 0.130, n 18), 95% CI -0.71 to +0.12. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.32 (p 0.198, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.45 (p 0.063, n 18). could be the mix.
skeptic
leave-one-out range -0.52 to -0.28, sign flips 0; without severely affected donors -0.37 (p 0.130, n 18). fragile.
cell type
strongest in microglia: -0.69 (p 0.0014, n 18) vs -0.37 in dopamine neurons. proposing microglia.
axis
no measure beats "tracks Braak Lewy-body stage" for SARM1 in dopamine neurons.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SARM1 · microglia · braak: substantia nigra, an independent cohort (already registered)

receipt 5661: SARM1 in oligodendrocytes, braak

power
full sample +0.03 (p 0.922, n 18), 95% CI -0.45 to +0.49. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.07 (p 0.794, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.00 (p 0.990, n 18). could be the mix.
skeptic
leave-one-out range -0.09 to +0.15, sign flips 6; without severely affected donors +0.03 (p 0.922, n 18). fragile.
cell type
strongest in microglia: -0.69 (p 0.0014, n 18) vs +0.03 in oligodendrocytes. proposing microglia.
axis
no measure beats "tracks Braak Lewy-body stage" for SARM1 in oligodendrocytes.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SARM1 · microglia · braak: substantia nigra, an independent cohort: not measured

Receipts

loading the receipts